Research Overview: Patadin
Patadin 5mg is a desloratadine-based pharmaceutical formulation developed by Ajanta Pharma for investigating antihistamine mechanisms in controlled laboratory environments. As a third-generation H1-receptor antagonist, this compound enables researchers at Stroid UK Shop to study selective histamine pathway modulation without the sedative effects associated with first-generation antihistamines. The desloratadine active ingredient demonstrates high selectivity for peripheral H1-receptors while maintaining minimal blood-brain barrier penetration in preclinical models, making it valuable for examining allergic cascade mechanisms and inflammatory mediator release patterns.
Laboratory Applications
Research teams examine Patadin 5mg in various experimental protocols investigating allergic response pathways, mast cell degranulation processes, and histamine-mediated inflammatory cascades. The compound’s pharmaceutical-grade formulation allows for precise dosometric studies in cell culture systems and tissue models. Scientists studying desloratadine mechanisms utilise this formulation to investigate receptor binding kinetics, metabolic pathways, and tissue distribution patterns. The non-sedating profile enables researchers to isolate peripheral antihistamine effects from central nervous system interactions, providing cleaner data sets for pharmacological analysis. Advanced laboratories also examine the compound’s interactions with cytochrome P450 enzyme systems and its role in modulating inflammatory mediator release from basophils and eosinophils.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Desloratadine 5mg |
| Manufacturer | Ajanta Pharma |
| Molecular Formula | C₁₉H₁₉ClN₂ |
| Molecular Weight | 310.82 g/mol |
| CAS Number | 100643-71-8 |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | Antihistamine mechanism studies |
The pharmaceutical-grade formulation maintains stability under standard laboratory conditions, enabling reproducible experimental outcomes. Research teams studying selective receptor modulators often compare antihistamine selectivity profiles with other receptor-specific compounds to understand tissue-selective pharmacological effects. The compound’s well-characterised pharmacokinetic profile provides researchers with established reference data for comparative studies involving histamine pathway modulation and allergic response mechanisms in various experimental models.
Research Compliance
Patadin 5mg from Ajanta Pharma is supplied exclusively for in-vitro laboratory research applications and is not intended for human consumption or therapeutic use. Researchers examining bioactive compounds should ensure proper laboratory protocols and safety measures are implemented when handling this pharmaceutical-grade research material. All experimental procedures should comply with institutional guidelines and relevant regulatory frameworks governing research chemical usage in laboratory environments.
